Serum levels of soluble interleukin-2 receptors and their relation to lymphocyte subpopulations in patients with metastatic solid tumours.

por Lissoni, P., Barni, S., Rescaldani, R., Rovelli, F., Tancini, G.
Publicado 1989

Serum interleukin-2 levels in relation to the neuroendocrine status in cancer patients.

por Lissoni, P., Tancini, G., Rovelli, F., Cattaneo, G., Archili, C., Barni, S.
Publicado 1990

In vivo stimulation of IL-12 secretion by subcutaneous low-dose IL-2 in metastatic cancer patients.

por Lissoni, P., Fumagalli, L., Rovelli, F., Brivio, F., Di Felice, G., Majorca, F.
Publicado 1998

Pretreatment serum markers and lymphocyte response to interleukin-2 therapy

por Fumagalli, L, Lissoni, P, Felice, G Di, Meregalli, S, Valsuani, G, Mengo, S, Rovelli, F
Publicado 1999

Evidence for altered opioid activity in patients with cancer.

por Lissoni, P., Barni, S., Paolorossi, F., Crispino, S., Rovelli, F., Ferri, L., Delitala, G., Tancini, G.
Publicado 1987

Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract.

por Lissoni, P., Barni, S., Tancini, G., Ardizzoia, A., Rovelli, F., Cazzaniga, M., Brivio, F., Piperno, A., Aldeghi, R., Fossati, D.
Publicado 1993

A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and me...

por Lissoni, P., Barni, S., Tancini, G., Ardizzoia, A., Ricci, G., Aldeghi, R., Brivio, F., Tisi, E., Rovelli, F., Rescaldani, R.
Publicado 1994

Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer.

por Lissoni, P., Tisi, E., Barni, S., Ardizzoia, A., Rovelli, F., Rescaldani, R., Ballabio, D., Benenti, C., Angeli, M., Tancini, G.
Publicado 1992